Shares in Staar Surgical (NSDQ:STAA) have risen in after-hours trading today after the medical device maker beat expectations on Wall Street with its third quarter results. The Monrovia, Calif.-based company posted profits of approximately $1.5 million, or 3¢ per share, on sales of approximately $31.8 million for the three months ended September 28, for bottom-line growth […]
STAAR Surgical Co
Staar Surgical wins FDA nod for Visian Toric ICL
Staar Surgical (NSDQ:STAA) said yesterday that it won FDA approval for its Visian toric implantable collamer lens designed for correcting myopia with astigmatism. The Monrovia, Calif.-based company said that with the approval, its ICL product line is now cleared for the correction of refractive errors in patients with both myopia and astigmatism. Staar Surgical said that its […]
Staar Surgical prices $68m offering
Staar Surgical (NSDQ:STAA) today priced an upcoming offering of shares, looking to raise up to $67.8 million with proceeds slated to support commercialization of its Collamer lens products and other activities. In the offering, the Monrovia, Calif.-based company will look to float 1.7 million shares of its common stock at $39 per share. The offering will also […]
Staar Surgical inks multi-year deal with Japanese eye clinics
Staar Surgical (NSDQ:STAA) said today it inked a multi-year strategic cooperation deal with Japan’s Kobe Kanagawa Eye Clinic. Through the newly inked deal, Kobe Kanagawa Eye Clinics in Tokyo and Osaka will offer Staar’s EVO Visian ICL lenses to patients seeking alternatives to glasses or contact lenses through refractive eye treatments. “We are very excited that […]
FDA lifts Staar Surgical warning letter
Staar Surgical (NSDQ:STAA) said today that the FDA lifted a 2014 warning letter issued over design and quality issues at a plant in California. Inspections by the federal safety watchdog that year turned up 15 issues at the plant in Monrovia where the company makes its intraocular lenses. The warning letter cited missing design files for […]
Staar Surgical settles class action suit for $7m
Staar Surgical (NSDQ:STAA) inked a $7 million deal last year to settle claims that the company misled investors regarding regulatory violations spotted by the FDA at a Monrovia, Calif.-based manufacturing facility. The plaintiff, Edward Todd, initially alleged that Staar Surgical, ex-president & CEO Barry Caldwell, CFO Deborah Andrews and ex-CFO Stephen Brown failed to disclose problems […]
Ophthalmic device companies top The Street with Q4, FY2017 earnings
Ophthalmic device developers Glaukos (NYSE:GKOS) and Staar Surgical (NSDQ:STAA) this week posted fourth quarter and full fiscal year 2017 earnings that beat the streets, though only Glaukos has seen its shares rise in response. San Clemente, Calif.-based Glaukos posted profits of $1 million, or 3¢ per share, on sales of $41.7 million for the three months ended December […]
Staar Surgical plans pivotal of Visian EVO ICL presbyopia optic for Q1 2018
Staar Surgical (NSDQ:STAA) this week reported results from the feasibility clinical study of its Evo+ Visian ICL with aspheric optics designed to reduce presbyopia, and that based on the results it plans to launch a pivotal clinical study of the device during the 1st quarter next year. The Monrovia, Calif.-based company’s EVO+ Visian ICL is designed […]
Dentsply Sirona clears the deck, ousting chairman, CEO & COO | Personnel Moves, Oct. 3, 2017
Dentsply Sirona (NSDQ:XRAY) yesterday cleared the deck of its upper management, ousting its chairman, CEO and COO, appointing an interim chief executive and promoting from within for the interim operating chief role. That means chairman Bret Wise, CEO Jeffrey Slovin and COO Christopher Clark are out, replaced temporarily by Eric Brandt, Mark Thierer and Bob […]
Staar Surgical steady on Q2 beat
Shares in Staar Surgical (NSDQ:STAA) rose slightly today after the medical device maker met expectations on Wall Street with its 2nd quarter earnings results. The Monrovia, Calif.-based company posted losses of $971,000, or 2¢ per share, on sales of $21.9 million for the 3 months ended June 30, seeing losses shrink 54.7% while sales grew 4.6% […]
Staar Surgical settles shareholder class action suit for $7m
Staar Surgical (NSDQ:STAA) has reached a $7 million settlement deal to end an investor suit claiming that the company concealed problems at its California plant which resulted in an FDA warning letter, according to court documents posted this week. The company reached the settlement with the certified class of investors after 3 years of litigation, according […]